Applying Genomic Science to Thyroid FNA Diagnosis
Clinically validated in a large, prospective, multi-center, international, double-blind study, Thryoseq was found to have 94% Sensitivity, 82% Specificity, 97% NPV and 66% PPV
CBLPath combines the performance of an academic institution with the service of a local facility to help you deliver definitive diagnoses, ensure prompt treatment decisions and provide superior patient care.
CBLPath is dedicated to providing you with the tools needed to stay, informed and up-to-date in the ever changing laboratory landscape.
In addition to our expert medical diagnostic service, many of our customers also take advantage of many of the unique programs that we offer
CBLPath is unsurpassed in thyroid pathology expertise and offers ThyroSeq the leader in Thyroid nodules
See a full list of Insurance Providers that CBLPath partners with
We are here to help, follow the link to request a specimen pickup.